FridaySep 18, 2026 3:04 pm

QualityStocksNewsBreaks – Nano-X Imaging Ltd. (NASDAQ: NNOX) Is Building End-to-End Platform for the Future of Medical Imaging

Nanox (NASDAQ: NNOX) is positioning itself as an integrated medical imaging and healthcare technology company, combining proprietary digital X-ray hardware, FDA-cleared AI applications, cloud software, teleradiology, and healthcare IT into an end-to-end platform designed to support earlier disease detection and more efficient care. Its ecosystem includes Nanox.ARC and the next-generation Nanox.ARC X imaging systems, Nanox.AI algorithms for identifying potential signs of chronic disease, Nanox.CLOUD for imaging management, and services through USARAD, Nanox.MARKETPLACE and Nanox Health IT. The company is expanding commercial and clinical activity through relationships with organizations including RadNet, Cedars-Sinai, Corewell Health and Brigham and Women’s Hospital, while also…

Continue Reading

FridaySep 04, 2026 10:10 am

QualityStocksNewsBreaks – Nanox Imaging Ltd. (NASDAQ: NNOX) Expands Nanox.ARC Distribution in New England

Nanox (NASDAQ: NNOX), through its U.S.-based subsidiary Nanox Impact Inc., entered into a distribution agreement with Associated X-Ray Imaging Corp. to support deployment of the Nanox.ARC across New England. Under the agreement, Associated X-Ray Imaging will market, distribute and support the FDA-cleared, multisource 3D digital tomosynthesis system, leveraging its regional customer relationships and service infrastructure. The agreement expands Nanox’s U.S. channel partner network and is intended to increase access to the Nanox.ARC in outpatient and community-based clinical settings across targeted markets. To view the full press release, visit https://ibn.fm/ChGtd About Nanox Nanox (NASDAQ: NNOX) is focused on driving the world’s…

Continue Reading

WednesdayAug 26, 2026 9:00 am

QualityStocksNewsBreaks – Nanox Imaging Ltd. (NASDAQ: NNOX) to Report Second-Quarter 2026 Financial Results Sept. 9

Nanox (NASDAQ: NNOX), an innovative medical imaging technology company, announced it will report financial results for the quarter ended June 30, 2026, before market open on Sept. 9, 2026. CEO and Acting Chairman Erez Meltzer and CFO Guy Nathanzon will host a conference call beginning at 8:30 a.m. ET to review the results and provide a business update. A live webcast will also be available through the Investor Relations section of the Nanox website. To view the full press release, visit https://ibn.fm/y877D About Nanox Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by delivering…

Continue Reading

TuesdayAug 25, 2026 9:00 am

Nano-X Imaging Ltd. (NASDAQ: NNOX) Is ‘One to Watch’

The company combines proprietary imaging hardware, FDA-cleared AI applications, cloud software, radiology services and healthcare IT within an end-to-end platform spanning scan, analysis and interpretation. Nanox is expanding its commercial reach through its U.S. commercial activities and collaboration with healthcare organizations. First-quarter 2026 revenue increased to $4.3 million from $2.8 million in the prior-year period, with contributions from teleradiology, imaging systems, OEM services, AI, software and Health IT. Nanox has secured FDA clearance for Nanox.ARC, Nanox.ARC X and three Nanox.AI medical imaging solutions, while its commercial and clinical activities involve organizations including RadNet, Cedars-Sinai, Corewell Health and Brigham and Women’s…

Continue Reading

ThursdayAug 06, 2026 10:20 am

QualityStocksNewsBreaks – NANO-X IMAGING LTD (NASDAQ: NNOX) Announces $8 Million Registered Direct Offering

NANO-X IMAGING (NASDAQ: NNOX) announced a securities purchase agreement with a single long-term institutional investor for a registered direct offering expected to generate approximately $8 million in gross proceeds before fees and expenses. The financing includes the sale of 8 million ordinary shares, or prefunded warrants in lieu thereof, together with warrants to purchase up to an additional 8 million ordinary shares at a combined purchase price of $1.00 per share and accompanying warrant. The warrants will carry a $1.15 exercise price, become exercisable six months after issuance and expire five years after closing. The offering is expected to close…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered